• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类端粒酶中一种锚定位点型缺陷,该缺陷会破坏端粒长度维持和细胞永生化。

An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.

作者信息

Moriarty Tara J, Ward Ryan J, Taboski Michael A S, Autexier Chantal

机构信息

Department of Anatomy and Cell Biology, Experimental Medicine Division, McGill University, Montréal, Québec H3A 2B2, Canada.

出版信息

Mol Biol Cell. 2005 Jul;16(7):3152-61. doi: 10.1091/mbc.e05-02-0148. Epub 2005 Apr 27.

DOI:10.1091/mbc.e05-02-0148
PMID:15857955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1165400/
Abstract

Telomerase-mediated telomeric DNA synthesis is important for eukaryotic cell immortality. Telomerase adds tracts of short telomeric repeats to DNA substrates using a unique repeat addition form of processivity. It has been proposed that repeat addition processivity is partly regulated by a telomerase reverse transcriptase (TERT)-dependent anchor site; however, anchor site-mediating residues have not been identified in any TERT. We report the characterization of an N-terminal human TERT (hTERT) RNA interaction domain 1 (RID1) mutation that caused telomerase activity defects consistent with disruption of a template-proximal anchor site, including reduced processivity on short telomeric primers and reduced activity on substrates with nontelomeric 5' sequences, but not on primers with nontelomeric G-rich 5' sequences. This mutation was located within a subregion of RID1 previously implicated in biological telomerase functions unrelated to catalytic activity (N-DAT domain). Other N-DAT and C-terminal DAT (C-DAT) mutants and a C-terminally tagged hTERT-HA variant were defective in elongating short telomeric primers, and catalytic phenotypes of DAT variants were partially or completely rescued by increasing concentrations of DNA primers. These observations imply that RID1 and the hTERT C terminus contribute to telomerase's affinity for its substrate, and that RID1 may form part of the human telomerase anchor site.

摘要

端粒酶介导的端粒DNA合成对于真核细胞的永生至关重要。端粒酶利用一种独特的持续合成重复序列的形式,将短的端粒重复序列片段添加到DNA底物上。有人提出,重复序列添加的持续性部分受端粒酶逆转录酶(TERT)依赖性锚定位点的调节;然而,在任何TERT中都尚未鉴定出介导锚定位点的残基。我们报告了一种N端人TERT(hTERT)RNA相互作用结构域1(RID1)突变的特征,该突变导致端粒酶活性缺陷,这与模板近端锚定位点的破坏一致,包括在短端粒引物上的持续性降低以及在具有非端粒5'序列的底物上的活性降低,但在具有富含G的非端粒5'序列的引物上则没有。该突变位于RID1的一个亚区域内,该亚区域先前与与催化活性无关的生物端粒酶功能有关(N-DAT结构域)。其他N-DAT和C端DAT(C-DAT)突变体以及C端标记的hTERT-HA变体在延长短端粒引物方面存在缺陷,并且通过增加DNA引物的浓度可以部分或完全挽救DAT变体的催化表型。这些观察结果表明,RID1和hTERT C端有助于端粒酶对其底物的亲和力,并且RID1可能构成人端粒酶锚定位点的一部分。

相似文献

1
An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.人类端粒酶中一种锚定位点型缺陷,该缺陷会破坏端粒长度维持和细胞永生化。
Mol Biol Cell. 2005 Jul;16(7):3152-61. doi: 10.1091/mbc.e05-02-0148. Epub 2005 Apr 27.
2
A physical and functional constituent of telomerase anchor site.端粒酶锚定位点的一种物理和功能成分。
J Biol Chem. 2005 Jul 15;280(28):26586-91. doi: 10.1074/jbc.M503028200. Epub 2005 May 18.
3
Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.人类端粒酶多聚体中重复序列添加持续性和DNA合成决定因素的功能组织
Mol Cell Biol. 2004 May;24(9):3720-33. doi: 10.1128/MCB.24.9.3720-3733.2004.
4
The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.人端粒酶逆转录酶的C末端是酶持续合成能力的决定因素。
Nucleic Acids Res. 2003 Jul 15;31(14):4059-70. doi: 10.1093/nar/gkg437.
5
A translocation-defective telomerase with low levels of activity and processivity stabilizes short telomeres and confers immortalization.活性和进程效率较低的转位缺陷端粒酶可稳定短端粒并赋予永生化。
Mol Biol Cell. 2013 May;24(9):1469-79. doi: 10.1091/mbc.E12-12-0889. Epub 2013 Feb 27.
6
A mutation in the catalytic subunit of yeast telomerase alters primer-template alignment while promoting processivity and protein-DNA binding.酵母端粒酶催化亚基的突变改变了引物-模板的排列,同时促进了延伸性和蛋白-DNA 结合。
J Cell Sci. 2011 Dec 15;124(Pt 24):4241-52. doi: 10.1242/jcs.090761. Epub 2011 Dec 22.
7
Human telomerase reverse transcriptase motifs required for elongation of a telomeric substrate.端粒底物延伸所需的人类端粒酶逆转录酶基序。
J Biol Chem. 2003 Dec 26;278(52):52531-6. doi: 10.1074/jbc.M311359200. Epub 2003 Oct 17.
8
Mutation in TERT separates processivity from anchor-site function.端粒酶逆转录酶(TERT)中的突变将持续合成能力与锚定位点功能区分开来。
Nat Struct Mol Biol. 2008 Aug;15(8):870-2. doi: 10.1038/nsmb.1462. Epub 2008 Jul 20.
9
Telomerase activity does not always imply telomere maintenance.端粒酶活性并不总是意味着端粒维持。
Biochem Biophys Res Commun. 1999 Jan 27;254(3):795-803. doi: 10.1006/bbrc.1998.0114.
10
Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo.人类端粒酶逆转录酶 (hTERT) Q169 对于端粒酶在体外和体内的功能至关重要。
PLoS One. 2009 Sep 24;4(9):e7176. doi: 10.1371/journal.pone.0007176.

引用本文的文献

1
Therapeutic Targets in Telomerase and Telomere Biology of Cancers.癌症端粒酶和端粒生物学中的治疗靶点
Indian J Clin Biochem. 2020 Apr;35(2):135-146. doi: 10.1007/s12291-020-00876-8. Epub 2020 Mar 10.
2
Quantitative Biology of Human Shelterin and Telomerase: Searching for the Weakest Point.人类端粒酶和 shelterin 蛋白的定量生物学研究:探寻薄弱环节。
Int J Mol Sci. 2019 Jun 28;20(13):3186. doi: 10.3390/ijms20133186.
3
Telomeres in health and disease.健康与疾病中的端粒。
J Oral Maxillofac Pathol. 2017 Jan-Apr;21(1):87-91. doi: 10.4103/jomfp.JOMFP_39_16.
4
Identification of an RNA aptamer binding hTERT-derived peptide and inhibiting telomerase activity in MCF7 cells.一种结合人端粒酶逆转录酶(hTERT)衍生肽并抑制MCF7细胞中端粒酶活性的RNA适配体的鉴定。
Mol Cell Biochem. 2017 Mar;427(1-2):157-167. doi: 10.1007/s11010-016-2907-7. Epub 2016 Dec 21.
5
Telomerase Regulation from Beginning to the End.端粒酶调控:从始至终
Genes (Basel). 2016 Sep 14;7(9):64. doi: 10.3390/genes7090064.
6
A translocation-defective telomerase with low levels of activity and processivity stabilizes short telomeres and confers immortalization.活性和进程效率较低的转位缺陷端粒酶可稳定短端粒并赋予永生化。
Mol Biol Cell. 2013 May;24(9):1469-79. doi: 10.1091/mbc.E12-12-0889. Epub 2013 Feb 27.
7
Finding the end: recruitment of telomerase to telomeres.找到终点:端粒酶向端粒的招募。
Nat Rev Mol Cell Biol. 2013 Feb;14(2):69-82. doi: 10.1038/nrm3505. Epub 2013 Jan 9.
8
The human telomerase catalytic subunit and viral telomerase RNA reconstitute a functional telomerase complex in a cell-free system, but not in human cells.在无细胞系统中,人类端粒酶催化亚基和病毒端粒酶 RNA 可重建具有功能的端粒酶复合物,但在人类细胞中不行。
Cell Mol Biol Lett. 2012 Dec;17(4):598-615. doi: 10.2478/s11658-012-0031-6. Epub 2012 Sep 1.
9
Tracing the path of DNA substrates in active Tetrahymena telomerase holoenzyme complexes: mapping of DNA contact sites in the RNA subunit.追踪活性四膜虫端粒酶全酶复合物中 DNA 底物的路径:RNA 亚基中 DNA 结合位点的作图。
Nucleic Acids Res. 2012 Aug;40(15):7430-41. doi: 10.1093/nar/gks416. Epub 2012 May 14.
10
A mutation in the catalytic subunit of yeast telomerase alters primer-template alignment while promoting processivity and protein-DNA binding.酵母端粒酶催化亚基的突变改变了引物-模板的排列,同时促进了延伸性和蛋白-DNA 结合。
J Cell Sci. 2011 Dec 15;124(Pt 24):4241-52. doi: 10.1242/jcs.090761. Epub 2011 Dec 22.

本文引用的文献

1
Switching human telomerase on and off with hPOT1 protein in vitro.在体外利用人端粒保护蛋白1(hPOT1)蛋白开关人类端粒酶
J Biol Chem. 2005 May 27;280(21):20449-56. doi: 10.1074/jbc.M502212200. Epub 2005 Mar 24.
2
Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.人端粒保护蛋白1(POT1)在体外是端粒酶活性的负调节因子。
Mol Cell Biol. 2005 Jan;25(2):808-18. doi: 10.1128/MCB.25.2.808-818.2005.
3
Processive utilization of the human telomerase template: lack of a requirement for template switching.人类端粒酶模板的持续利用:对模板转换无需求
J Biol Chem. 2004 Dec 17;279(51):53770-81. doi: 10.1074/jbc.M407768200. Epub 2004 Sep 27.
4
Adding to the ends: what makes telomerase processive and how important is it?末端延伸:是什么使得端粒酶具有持续性,以及其重要性如何?
Bioessays. 2004 Sep;26(9):955-62. doi: 10.1002/bies.20093.
5
A human telomerase-associated nuclease.一种人类端粒酶相关核酸酶。
Mol Biol Cell. 2004 Jul;15(7):3244-56. doi: 10.1091/mbc.e04-03-0178. Epub 2004 Apr 30.
6
Human telomerase catalyzes nucleolytic primer cleavage.人类端粒酶催化核酸内切引物切割。
Nucleic Acids Res. 2004 Apr 19;32(7):2171-80. doi: 10.1093/nar/gkh546. Print 2004.
7
Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.人类端粒酶多聚体中重复序列添加持续性和DNA合成决定因素的功能组织
Mol Cell Biol. 2004 May;24(9):3720-33. doi: 10.1128/MCB.24.9.3720-3733.2004.
8
Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1.通过与hPot1融合挽救端粒延长缺陷的hTERT突变体。
Mol Cell Biol. 2004 Apr;24(8):3552-61. doi: 10.1128/MCB.24.8.3552-3561.2004.
9
Human telomerase reverse transcriptase motifs required for elongation of a telomeric substrate.端粒底物延伸所需的人类端粒酶逆转录酶基序。
J Biol Chem. 2003 Dec 26;278(52):52531-6. doi: 10.1074/jbc.M311359200. Epub 2003 Oct 17.
10
Catalytically active human telomerase mutants with allele-specific biological properties.具有等位基因特异性生物学特性的催化活性人端粒酶突变体。
Exp Cell Res. 2003 Aug 15;288(2):277-87. doi: 10.1016/s0014-4827(03)00217-9.